Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Scholar Rock Holding Corp

Get SEC filing alerts via email and in your feed for Scholar Rock Holding Corp

SRRK

Scholar Rock Holding Corp

About Scholar Rock Holding Corp

Scholar Rock is a biopharmaceutical company specializing in the discovery and development of monoclonal antibodies targeting latent growth factors, primarily within the TGF-β superfamily. Its proprietary platform enables selective inhibition of growth factor activation in disease microenvironments, aiming to treat neuromuscular disorders, cancer, fibrosis, and cardiometabolic diseases. The company’s lead candidate, apitegromab, targets muscle atrophy in SMA, while others focus on cancer and fibrosis, emphasizing precision medicine and innovative therapeutic approaches.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Scholar Rock Holding Corp

1
1
Scholar Rock Holding Corp Scholar Rock Reports $105.5 Million Net Loss in Q1 2026, Increases Cash Reserves to $430.5 Million

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Scholar Rock Holding Corp Scholar Rock Reports 2025 Financial Results and Strategic Developments

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Scholar Rock Holding Corp Scholar Rock Reports $102.2 Million Net Loss in Q3 2025, Operating Expenses Surge

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Scholar Rock Holding Corp Scholar Rock Reports $110M Net Loss in Q2 2025, Advances Product Pipeline

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Scholar Rock Holding Corp Scholar Rock Reports $74.7 Million Net Loss in Q1 2025, Increases Focus on Apitegromab

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Scholar Rock Holding Corp Scholar Rock Reports Significant Decline in Assets, Increased Operating Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments